top of page

Frontiers Topic Open for Submissions - Enzymes in Brain Trauma and Disease

Frontiers is the 3rd most-cited research publisher and reports groundbreaking discoveries by the world's top experts. Frontiers, Experimental Therapeutics is now accepting submissions that highlight the roles of enzymes in neurological injury or disease. Authors are also encouraged to submit relevant work describing enzymes associated with infectious agents, e.g. SARS-CoV-2, as applicable to neurological symptoms and / or damage.


Visit Frontiers to learn more



To learn how we can assist with your needs within science and medicine, visit Aries Biotech at https://www.ariesbiotechnologies.org.

 
 
 

Recent Posts

See All

Comments


Golden Gate Bridge

Contact Us

Thank you. Aries Biotech will respond shortly.

Aries Biotech Consulting
4440 Keller Avenue, Suite 140, Box 199, Oakland, CA 94605
E-mail:  ariesbiotech.consult@gmail.com
Office
/Msg Ph:  650-246-9476

 

Subscribe for News and Updates

Thanks for submitting!

Disclaimer - This site and services are solely affiliated with Aries Biotech.
Name and logo are protected by trademark (USPTO No. 5826  and No. 5827).

bottom of page